DingoBorat
Slim
Yeah, my feet are getting cold already..
Not because of the sharks, just cutting everything else, just a bit too fine..
BRN Discussion Ongoing
- Thread starter TechGirl
- Start date
Not because of the sharks, just cutting everything else, just a bit too fine..
Fullmoonfever
Top 20
Nice to see the Airbus team excited with the recent news of our partnership giving it a share.
www.linkedin.com
Jérémy Lebreton on LinkedIn: Thank you, BrainChip team, for sharing the news. At Airbus, we are very…
Thank you, BrainChip team, for sharing the news. At Airbus, we are very glad to be starting this new ESA R&T project called NEURAVIS with BrainChip , Neurobus…
Sitting in the same boat fella! But what about that “there is no right, because you never know”
Tony Coles
Regular
Hi DB, I hope I get caught out of guard at 16, if it reaches there. Nice order just sitting there incase.Just bought another 5000 shares Pom
Actually caught me a little off guard..
Had them in at 18 cents (at the bottom) and still working out transfer times etc..
And then Boom, they are bought, via a big dump into the sell side.
I may have to do some creative accounting, over the next couple of days.. (money coming from PayPal, from sale of goods and they say 3 -5 business days..) So I think I'm going to have to double up payment, from my bank account, which genuinely leaves me skits, until I can transfer the money back from my Comsec account..
Hi Tony,
Fairly light trade so far (< 4M at 3 o'clock)- no sign of panic selling.
Since I can't afford any more, I'm hoping for FOMO to kick in any day now.
Fullmoonfever
Top 20
Wonder if we will get a look in somewhere in the background 
www.prnewswire.co.uk
NEWS PROVIDED BY
Tata Elxsi Ltd
05 Aug, 2024, 07:01 GMT
BENGALURU, India, Aug. 5, 2024 /PRNewswire/ -- Skanray, a leading global MedTech R&D and Manufacturing company specialising in diagnostic imaging, critical care and surgery/OT solutions, has chosen Tata Elxsi as a strategic partner for advanced surgical imaging core technology and software platform development. This collaboration aims to revolutionise diagnosis and treatment by leveraging cutting-edge technology modules, making them predictable, accurate, and consistent.
Skanray is actively pursuing a long-term strategy to expand its portfolio by including new device families and modalities. This initiative aims to build a suite of reusable modules and components for medical devices, alongside the development of an advanced analytics cloud platform.
Tata Elxsi will lead a software platform-led approach to diagnostics that will support all imaging, critical care and surgical systems from the Skanray family, ensuring interoperability, compatibility and multi-modal functionality. This platform will also incorporate the latest technologies and process efficiencies from AI and GenAI.
Combining Skanray's expertise in medical devices, core component technology, systems and applications with Tata Elxsi's domain experience in medical imaging, software platform development, digital capabilities in cloud, AI and analytics, and ready-to-use solution accelerators provides Skanray an opportunity to redefine the landscape of medical technology, with advanced, modular, and yet affordable diagnostics systems.
Pankaj Madhukar Wani, Head of Healthcare Business Unit at Tata Elxsi, said, "The diagnostic imaging landscape is being transformed by software and digital technologies such as cloud and AI. We are delighted to be supporting Skanray in realising their long-term strategy and vision for healthcare. This long-term partnership will help create transformative solutions for healthcare facilities and patients worldwide."
"By combining Skanray's core technology and deep understanding of medical applications with Tata Elxsi's capabilities in futuristic technology, we are poised to drive significant advancements in healthcare delivery. Our collaborative efforts will result in solutions that are not only technologically advanced, but are also operator-friendly and cost-effective, helping healthcare providers deliver significantly improved health outcomes for patients," said Priyanka Chatterjee, VP – Corporate Communications at Skanray Technologies Ltd.
About Tata Elxsi
Tata Elxsi is a global design and technology services company headquartered in Bangalore. It addresses the healthcare, automotive, broadcast, and communications consumer electronics industries. This is supported by a network of design studios, development centres, and offices worldwide.
Tata Elxsi's Healthcare & Life Sciences practice is ISO 13485 certified and collaborates with prominent medical device and pharmaceutical OEMs, as well as technology companies. With a comprehensive services and solutions portfolio, Tata Elxsi adds value at every stage of the customer's product development lifecycle. Recognised as a leader in technology consulting, new product design, development, verification & validation, as well as regulatory compliance services, Tata Elxsi is a trusted name in the industry.
About Skanray
Skanray is a leading MedTech R&D company with operations in 7 countries . Skanray offers 55 CE marked and 34 FDA approved products in diagnostics imaging, critical care, cardiology, dental and in the surgical space.
With a portfolio boasting over 80 patents, Skanray contributes to more than 150,000 installations in 80 countries, across the globe
Skanray Partners with Tata Elxsi to Advance Surgical Imaging and Healthcare Innovation
/PRNewswire/ -- Skanray, a leading global MedTech R&D and Manufacturing company specialising in diagnostic imaging, critical care and surgery/OT solutions, has...
Skanray Partners with Tata Elxsi to Advance Surgical Imaging and Healthcare Innovation
NEWS PROVIDED BY
Tata Elxsi Ltd
05 Aug, 2024, 07:01 GMT
BENGALURU, India, Aug. 5, 2024 /PRNewswire/ -- Skanray, a leading global MedTech R&D and Manufacturing company specialising in diagnostic imaging, critical care and surgery/OT solutions, has chosen Tata Elxsi as a strategic partner for advanced surgical imaging core technology and software platform development. This collaboration aims to revolutionise diagnosis and treatment by leveraging cutting-edge technology modules, making them predictable, accurate, and consistent.
Skanray is actively pursuing a long-term strategy to expand its portfolio by including new device families and modalities. This initiative aims to build a suite of reusable modules and components for medical devices, alongside the development of an advanced analytics cloud platform.
Tata Elxsi will lead a software platform-led approach to diagnostics that will support all imaging, critical care and surgical systems from the Skanray family, ensuring interoperability, compatibility and multi-modal functionality. This platform will also incorporate the latest technologies and process efficiencies from AI and GenAI.
Combining Skanray's expertise in medical devices, core component technology, systems and applications with Tata Elxsi's domain experience in medical imaging, software platform development, digital capabilities in cloud, AI and analytics, and ready-to-use solution accelerators provides Skanray an opportunity to redefine the landscape of medical technology, with advanced, modular, and yet affordable diagnostics systems.
Pankaj Madhukar Wani, Head of Healthcare Business Unit at Tata Elxsi, said, "The diagnostic imaging landscape is being transformed by software and digital technologies such as cloud and AI. We are delighted to be supporting Skanray in realising their long-term strategy and vision for healthcare. This long-term partnership will help create transformative solutions for healthcare facilities and patients worldwide."
"By combining Skanray's core technology and deep understanding of medical applications with Tata Elxsi's capabilities in futuristic technology, we are poised to drive significant advancements in healthcare delivery. Our collaborative efforts will result in solutions that are not only technologically advanced, but are also operator-friendly and cost-effective, helping healthcare providers deliver significantly improved health outcomes for patients," said Priyanka Chatterjee, VP – Corporate Communications at Skanray Technologies Ltd.
About Tata Elxsi
Tata Elxsi is a global design and technology services company headquartered in Bangalore. It addresses the healthcare, automotive, broadcast, and communications consumer electronics industries. This is supported by a network of design studios, development centres, and offices worldwide.
Tata Elxsi's Healthcare & Life Sciences practice is ISO 13485 certified and collaborates with prominent medical device and pharmaceutical OEMs, as well as technology companies. With a comprehensive services and solutions portfolio, Tata Elxsi adds value at every stage of the customer's product development lifecycle. Recognised as a leader in technology consulting, new product design, development, verification & validation, as well as regulatory compliance services, Tata Elxsi is a trusted name in the industry.
About Skanray
Skanray is a leading MedTech R&D company with operations in 7 countries . Skanray offers 55 CE marked and 34 FDA approved products in diagnostics imaging, critical care, cardiology, dental and in the surgical space.
With a portfolio boasting over 80 patents, Skanray contributes to more than 150,000 installations in 80 countries, across the globe
Fullmoonfever
Top 20
Further to some previous excellent digging by @cosors and @Frangipani this guy who used to work at Tata Elxsi did some time at FZI and my guess worked with Akida there too by the looks. Timeline of work fits as does scope.
thestockexchange.com.au
thestockexchange.com.au
BRN Discussion Ongoing
Well said Tech. I couldn’t agree more. Well said Rob .......
thestockexchange.com.au
BRN Discussion Ongoing
Very weird BRN released this news so early, this sort of tells me we ain’t go get much news/revenue before the AGM, so are they are trying to soften the blow? Hope I’m wrong Sorry, but this article was published on 14th April 2020. :unsure:
thestockexchange.com.au
Yeah
prwire.com.au
Pioneering Founder of BrainChip Peter van der Made Recognised with 2024 Western Australian Pearcey Award
The Pearcey Foundation today announced Peter van der Made, founder of BrainChip, as the recipient of the 2024 Western Australian Pearcey Entrepreneur of the Year Award. The award was presented as part of the 33rd annual WAITTA INCITE Awards, Western...
Quiltman
Regular
Wonder if we will get a look in somewhere in the background
Skanray Partners with Tata Elxsi to Advance Surgical Imaging and Healthcare Innovation
/PRNewswire/ -- Skanray, a leading global MedTech R&D and Manufacturing company specialising in diagnostic imaging, critical care and surgery/OT solutions, has...
Skanray Partners with Tata Elxsi to Advance Surgical Imaging and Healthcare Innovation
NEWS PROVIDED BY
Tata Elxsi Ltd
05 Aug, 2024, 07:01 GMT
BENGALURU, India, Aug. 5, 2024 /PRNewswire/ -- Skanray, a leading global MedTech R&D and Manufacturing company specialising in diagnostic imaging, critical care and surgery/OT solutions, has chosen Tata Elxsi as a strategic partner for advanced surgical imaging core technology and software platform development. This collaboration aims to revolutionise diagnosis and treatment by leveraging cutting-edge technology modules, making them predictable, accurate, and consistent.
Skanray is actively pursuing a long-term strategy to expand its portfolio by including new device families and modalities. This initiative aims to build a suite of reusable modules and components for medical devices, alongside the development of an advanced analytics cloud platform.
Tata Elxsi will lead a software platform-led approach to diagnostics that will support all imaging, critical care and surgical systems from the Skanray family, ensuring interoperability, compatibility and multi-modal functionality. This platform will also incorporate the latest technologies and process efficiencies from AI and GenAI.
Combining Skanray's expertise in medical devices, core component technology, systems and applications with Tata Elxsi's domain experience in medical imaging, software platform development, digital capabilities in cloud, AI and analytics, and ready-to-use solution accelerators provides Skanray an opportunity to redefine the landscape of medical technology, with advanced, modular, and yet affordable diagnostics systems.
Pankaj Madhukar Wani, Head of Healthcare Business Unit at Tata Elxsi, said, "The diagnostic imaging landscape is being transformed by software and digital technologies such as cloud and AI. We are delighted to be supporting Skanray in realising their long-term strategy and vision for healthcare. This long-term partnership will help create transformative solutions for healthcare facilities and patients worldwide."
"By combining Skanray's core technology and deep understanding of medical applications with Tata Elxsi's capabilities in futuristic technology, we are poised to drive significant advancements in healthcare delivery. Our collaborative efforts will result in solutions that are not only technologically advanced, but are also operator-friendly and cost-effective, helping healthcare providers deliver significantly improved health outcomes for patients," said Priyanka Chatterjee, VP – Corporate Communications at Skanray Technologies Ltd.
About Tata Elxsi
Tata Elxsi is a global design and technology services company headquartered in Bangalore. It addresses the healthcare, automotive, broadcast, and communications consumer electronics industries. This is supported by a network of design studios, development centres, and offices worldwide.
Tata Elxsi's Healthcare & Life Sciences practice is ISO 13485 certified and collaborates with prominent medical device and pharmaceutical OEMs, as well as technology companies. With a comprehensive services and solutions portfolio, Tata Elxsi adds value at every stage of the customer's product development lifecycle. Recognised as a leader in technology consulting, new product design, development, verification & validation, as well as regulatory compliance services, Tata Elxsi is a trusted name in the industry.
About Skanray
Skanray is a leading MedTech R&D company with operations in 7 countries . Skanray offers 55 CE marked and 34 FDA approved products in diagnostics imaging, critical care, cardiology, dental and in the surgical space.
With a portfolio boasting over 80 patents, Skanray contributes to more than 150,000 installations in 80 countries, across the globe
Here is your answer I reckon :
Sayan Kahali, Consultant Research Scientist at TCS.
Currently developing Spiking Neural Network models for low power edge applications.
Works with Sounak Dey - our BrainChip evangelist with TCS.
Key interests around Biomedical image analysis, 3D Medical Imaging, Quantitative Brain MR imaging and related applications.
Very good chance that Sayan has been hired on a project basis to work on Spiking Neural models for Skanray with their IP partners ( Brainchip ) technology
AI_Inquirer
Regular
https://thestockexchange.com.au/threads/brn-discussion-ongoing.1/post-433475
https://thestockexchange.com.au/threads/brn-discussion-ongoing.1/post-433479
Hi @DingoBorat and @Diogenese
AGM May 2024 -
Tony Lewis: well so TENNs is a competitor against, existing neural networks, our customers have a view of the world that is pre TENNs they have to be introduced to the technology and they're being introduced in a stage manner we're going out we're talking about TENNs we're publishing papers we're getting people familiarised I believe that once they're familiarised with TENNs they're going to see that we can use it for all sorts of things so we're proving out how we can use it for audio de-noising as you saw there but also ASR is on our agenda, processing biomedical samples that's on our agenda and also these large language models and so we're proving out what we can do with TENNs and once we have those proof points we can go to customers and say hey guys this is going to be you should go with TENNs because it's going to be a lot more power efficient than what you're using right now it's going to be good for you eat your vegetables and you know learn about our technology.
Sean: before the next question comes a couple of themes that came out if you heard my speech, we were going to put more resources into TENNs so more development.
Tony’s comments from just three months ago, along with the recent CR, SPP, and investor presentation from two weeks ago, make it hard for me to believe that we’ll be waking up to a trading halt involving the sale of TENNs IP or software anytime soon.
I like the team's efforts in building TENN's profile through articles, white paper, etc and by ensuring that there are multiple demos, models and possibly even simulation environments are ready before moving towards commercialisation. These lessons have clearly been learned from the experience with AKIDA when introducing a brand-new technology.
https://thestockexchange.com.au/threads/brn-discussion-ongoing.1/post-433479
Hi @DingoBorat and @Diogenese
AGM May 2024 -
Tony Lewis: well so TENNs is a competitor against, existing neural networks, our customers have a view of the world that is pre TENNs they have to be introduced to the technology and they're being introduced in a stage manner we're going out we're talking about TENNs we're publishing papers we're getting people familiarised I believe that once they're familiarised with TENNs they're going to see that we can use it for all sorts of things so we're proving out how we can use it for audio de-noising as you saw there but also ASR is on our agenda, processing biomedical samples that's on our agenda and also these large language models and so we're proving out what we can do with TENNs and once we have those proof points we can go to customers and say hey guys this is going to be you should go with TENNs because it's going to be a lot more power efficient than what you're using right now it's going to be good for you eat your vegetables and you know learn about our technology.
Sean: before the next question comes a couple of themes that came out if you heard my speech, we were going to put more resources into TENNs so more development.
Tony’s comments from just three months ago, along with the recent CR, SPP, and investor presentation from two weeks ago, make it hard for me to believe that we’ll be waking up to a trading halt involving the sale of TENNs IP or software anytime soon.
I like the team's efforts in building TENN's profile through articles, white paper, etc and by ensuring that there are multiple demos, models and possibly even simulation environments are ready before moving towards commercialisation. These lessons have clearly been learned from the experience with AKIDA when introducing a brand-new technology.
Fullmoonfever
Top 20
I know they've been advertising but looks like maybe using recruitment firm now too (not searched if cybercoders posted prev) and still trying or recently have fill the role.
Not my bold / highlighting.
Wonder how much poetic licence has been taken re where the chips are "currently" being used or if that is a Freudian slipped through
LinkedIn post HERE
Website
CyberCoders Mission Viejo, CA
Job Title: Machine Learning Engineer
Location: Hybrid in Laguna Hills, CA - 3 days onsite
Salary: $130,000 - $170,000+ Annual Base Salary (DOE), Large RSU's Package, Full Benefits, PTO, Bonuses, 401K
Requirements: 3+ years of Machine Learning experience, experience training large models with large numbers of GPUs, solid math foundation to comprehend what research scientists are creating
We are a well funded, small company that has been around for over 10 years creating chips that hold AI technology. Our chips are currently being used for electric vehicles, home security and surveillance, home intelligence and maintenance, manufacturing maintenance and management, robotics, automation, quality control, healthcare data, and fitness equipment!
Due to our increased workload, we are currently looking to add a Machine Learning Engineer to our experienced team in Laguna Hills, CA! We have about 40 employees but this person will be on our Machine Learning Team reporting to the CTO (about 5 engineers). This is an opportunity to develop AI using new algorithms that people have not seen before for new hardware that no one has programmed before! We are looking for talented candidates that have studied subjects like Theoretical Physics or AI.
Responsibilities
Not my bold / highlighting.
Wonder how much poetic licence has been taken re where the chips are "currently" being used or if that is a Freudian slipped through
LinkedIn post HERE
Website
I’m Recruiting for a Machine Learning Engineer in Laguna Hills, CA, Mission Viejo, CA, Aliso Viejo, CA.
Check it out! I am looking to hire a talented Machine Learning Engineer in Laguna Hills, CA, Mission Viejo, CA, Aliso Viejo, CA. If this fits you please apply! Or you might know someone who would like this job. Share it with them!
www.cybercoders.com
Machine Learning Engineer - 130K-170K - Hybrid in Laguna Hills
CyberCoders Mission Viejo, CA
2 weeks ago 136 applicants
Job Title: Machine Learning Engineer
Location: Hybrid in Laguna Hills, CA - 3 days onsite
Salary: $130,000 - $170,000+ Annual Base Salary (DOE), Large RSU's Package, Full Benefits, PTO, Bonuses, 401K
Requirements: 3+ years of Machine Learning experience, experience training large models with large numbers of GPUs, solid math foundation to comprehend what research scientists are creating
We are a well funded, small company that has been around for over 10 years creating chips that hold AI technology. Our chips are currently being used for electric vehicles, home security and surveillance, home intelligence and maintenance, manufacturing maintenance and management, robotics, automation, quality control, healthcare data, and fitness equipment!
Due to our increased workload, we are currently looking to add a Machine Learning Engineer to our experienced team in Laguna Hills, CA! We have about 40 employees but this person will be on our Machine Learning Team reporting to the CTO (about 5 engineers). This is an opportunity to develop AI using new algorithms that people have not seen before for new hardware that no one has programmed before! We are looking for talented candidates that have studied subjects like Theoretical Physics or AI.
Responsibilities
- Implement and optimize ML Algorithms for deployment on embedded systems
- Collaborate with research team to translate ML models
- Develop and maintain code in python, C, and C++ for real time systems
- Stay up to date with ML, embedded AI, and more AI/ML related technologies
- Enhance system performance by working on ML algorithm and hardware co-design
- Debug software to make sure it is performing efficiently on Akida
- Customer interfacing and intake to understand needs and problems, provide tech support for ML applications
- Help develop Akida software
- 3+ years of professional experience in ML
- Python
- C++
- RTOS
- Embedded AI
- Bachelor's Degree in Computer Science or Electrical Engineering
Given Tata Elxsi said they will drive AKIDA into Health its not a big leap to suggest we (BRN) is involved.Wonder if we will get a look in somewhere in the background
Skanray Partners with Tata Elxsi to Advance Surgical Imaging and Healthcare Innovation
/PRNewswire/ -- Skanray, a leading global MedTech R&D and Manufacturing company specialising in diagnostic imaging, critical care and surgery/OT solutions, has...
Skanray Partners with Tata Elxsi to Advance Surgical Imaging and Healthcare Innovation
NEWS PROVIDED BY
Tata Elxsi Ltd
05 Aug, 2024, 07:01 GMT
BENGALURU, India, Aug. 5, 2024 /PRNewswire/ -- Skanray, a leading global MedTech R&D and Manufacturing company specialising in diagnostic imaging, critical care and surgery/OT solutions, has chosen Tata Elxsi as a strategic partner for advanced surgical imaging core technology and software platform development. This collaboration aims to revolutionise diagnosis and treatment by leveraging cutting-edge technology modules, making them predictable, accurate, and consistent.
Skanray is actively pursuing a long-term strategy to expand its portfolio by including new device families and modalities. This initiative aims to build a suite of reusable modules and components for medical devices, alongside the development of an advanced analytics cloud platform.
Tata Elxsi will lead a software platform-led approach to diagnostics that will support all imaging, critical care and surgical systems from the Skanray family, ensuring interoperability, compatibility and multi-modal functionality. This platform will also incorporate the latest technologies and process efficiencies from AI and GenAI.
Combining Skanray's expertise in medical devices, core component technology, systems and applications with Tata Elxsi's domain experience in medical imaging, software platform development, digital capabilities in cloud, AI and analytics, and ready-to-use solution accelerators provides Skanray an opportunity to redefine the landscape of medical technology, with advanced, modular, and yet affordable diagnostics systems.
Pankaj Madhukar Wani, Head of Healthcare Business Unit at Tata Elxsi, said, "The diagnostic imaging landscape is being transformed by software and digital technologies such as cloud and AI. We are delighted to be supporting Skanray in realising their long-term strategy and vision for healthcare. This long-term partnership will help create transformative solutions for healthcare facilities and patients worldwide."
"By combining Skanray's core technology and deep understanding of medical applications with Tata Elxsi's capabilities in futuristic technology, we are poised to drive significant advancements in healthcare delivery. Our collaborative efforts will result in solutions that are not only technologically advanced, but are also operator-friendly and cost-effective, helping healthcare providers deliver significantly improved health outcomes for patients," said Priyanka Chatterjee, VP – Corporate Communications at Skanray Technologies Ltd.
About Tata Elxsi
Tata Elxsi is a global design and technology services company headquartered in Bangalore. It addresses the healthcare, automotive, broadcast, and communications consumer electronics industries. This is supported by a network of design studios, development centres, and offices worldwide.
Tata Elxsi's Healthcare & Life Sciences practice is ISO 13485 certified and collaborates with prominent medical device and pharmaceutical OEMs, as well as technology companies. With a comprehensive services and solutions portfolio, Tata Elxsi adds value at every stage of the customer's product development lifecycle. Recognised as a leader in technology consulting, new product design, development, verification & validation, as well as regulatory compliance services, Tata Elxsi is a trusted name in the industry.
About Skanray
Skanray is a leading MedTech R&D company with operations in 7 countries . Skanray offers 55 CE marked and 34 FDA approved products in diagnostics imaging, critical care, cardiology, dental and in the surgical space.
With a portfolio boasting over 80 patents, Skanray contributes to more than 150,000 installations in 80 countries, across the globe
Late in the Quarterly update with Tony, Sean spoke about TENNS improvements and said support for LLM's at the Edge would be available very soon. That could be IMO potentially huge in that it can take more work away from the cloud and position it to non cloud.
How soon is very soon? That does not mean sales soon but it provides another marketing tool. Regardless of the LLM plans i expect we will see some developments via the R & D cash.
Also I expect that Gen 3 should become a reality in 2025 hopefully in the 1st half half.
Where and how are they being used? Must not be in a commercial product or we'd be seeing revenue.
DingoBorat
Slim
Wait until you see Optimus 3, probably near the end of this year..
CHIPS
Regular
Yes, I can't wait to see how it will develop. I am also invested in Tesla because of Optimus.
That's a whole bunch of accelerometers and gyroscopes that could use an SNN.
Similar threads
